Syringocystadenocarcinoma papilliferum (SCACP) is a rare adenexal carcinoma with only 21 cases reported in the literature. Most patients describe a long-standing mass with recent change, supporting the idea that SCACP arises from malignant transformation of pre-existing syringocystadenoma papilliferum (SCAP).Syringocystadenocarcinoma papilliferum is generally treated with wide surgical excision of the lesion and patients do exceeding well and require no systemic therapy.
مجموعه
تاريخ نشر
2013
عنوان
Dermatology Online Journal
شماره جلد
19/9
نام شخص به منزله سر شناسه - (مسئولیت معنوی درجه اول )